Clinical Trial Update: Azacitidine and CAPOX in Metastatic Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating azacitidine plus CAPOX in metastatic colorectal cancer has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• CAPOX (capecitabine + oxaliplatin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-04-15